Skip to main content

Fonds Cauris Croissance II

Equity : October 2010

BIO has invested € 5 M in equity in Fonds Cauris Croissance II, a private equity fund dedicated to SMEs in West Africa.

Amount

€ 5,000,000.00

Type of investment

Equity

Development impacts

  • Local economic growth

Beneficiary locations

Africa: Benin, Burkina Faso, Cameroon, Côte d'Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Togo

Investment field

Investment Companies & Funds

Activity

SME Fund

Organisation

Fonds Cauris Croissance II

Domicile

Mauritius

Fonds Cauris Croissance II was launched in 2010. It focuses on companies with a regional development strategy and covers West Africa with the exception of Nigeria. Fonds Cauris Croissance II is the third fund managed by the Cauris Management team.

Development impacts

  • Local economic growth

    Effects at investee level: access to long-term financing for SMEs:
    The Fund is targeting SMEs in West-Africa to provide them with (i) long term capital, (ii) cross-competencies and (iii) access to new markets. There have been only few private equity groups that have been active in this field.

Made possible through this investment

Thanks to the direct funding from BIO, the following second-line investments have been made possible.

Atlantic Business International / Banque Atlantique

Benin, Burkina Faso, Côte d'Ivoire, Mali, Niger, Senegal, Togo

Banque Atlantique is a West African financial services conglomerate with subsidiaries in Benin, Burkina Faso, Côte d’Ivoire, Mali, Niger, Senegal and Togo.

Africa West Industries

Côte d'Ivoire

Africa West Industries (AWI) is a Cote d'Ivoire-based company which produces soap bars and soap pellets. Products are marketed within the West African market.

Axxend Corporation

Cameroon, Côte d'Ivoire, Ghana, Guinea, Senegal

Axxend Corporation (Axxend) is a business technology services provider, dedicated to using the Microsoft platform and SAP technologies to assist enterprises achieve higher efficiency and profitable growth. The company has operating subsidiaries in Senegal, Cote d’Ivoire, Ghana and Cameroon.

Cipharm

Côte d'Ivoire

CIPHARM is the Ivorian leader in pharmaceutical production, present for more than 25 years in the production of generic drugs (dry form, powder and syrup), own brand or licensed, distributed in a dozen countries in West and Central Africa.

SGH SA

Benin, Burkina Faso, Côte d'Ivoire, Guinea, Mali

SGH is Azalaï Hotel Group's Malian subsidiary which operates 4 hotels in Bamako: Hotel Salam, Grand Hotel, Hotel Nord-Sud and Hotel Dunia.

Vipnet

Côte d'Ivoire

Vipnet is a Cote d’Ivoire-based company incorporated in 1999 and providing interconnection, internet (B2B and B2C) and alternative telephony services (international communications through internet VoIP, call termination, etc.).

View more of our investments in this region

EA Foods Ltd

Enterprises

EA Foods Ltd

 44,119.00

  Tanzania

  03/04/2025

  Subsidy

Alterfin

Financial Institutions

Alterfin

 350,000.00

  25/03/2025

  Subsidy

ACEP Group

Financial Institutions

ACEP Group

 1,500,000.00

  Niger

  24/03/2025

  Debt

Gebana Burkina Faso

Enterprises

Gebana Burkina Faso

 24,244.00

  Burkina Faso

  16/01/2025

  Subsidy

Agroserv Industrie SA

Enterprises

Agroserv Industrie SA

 11,190.00

  Burkina Faso

  16/01/2025

  Subsidy

AfricInvest SME Fund

Investment Companies & Funds

AfricInvest SME Fund

 10,000,000.00

  Algeria, Egypt, Kenya, Morocco, Nigeria

  09/12/2024

  Equity

Renewable Energy Performance Platform 2

Investment Companies & Funds

Renewable Energy Performance Platform 2

15,000,000.00

  Cameroon, Democratic Republic of Congo, Lesotho, Madagascar, Malawi, Niger, Nigeria, Sierra Leone, Zambia

  06/12/2024

  Debt

African Rivers Fund IV

Investment Companies & Funds

African Rivers Fund IV

10,000,000.00

  Angola, Democratic Republic of Congo, Uganda, Zambia

  05/12/2024

  Equity

BRAC International Finance

Financial Institutions

BRAC International Finance

 7,934,984.64

  Tanzania

  08/11/2024

  Debt